Next Article in Journal
Public Health and Economic Benefits of Influenza Vaccination of the Population Aged 50 to 59 Years without Risk Factors for Influenza Complications in Mexico: A Cross-Sectional Epidemiological Study
Next Article in Special Issue
Impact of Biological Therapies on the Immune Response after Pneumococcal Vaccination in Patients with Autoimmune Inflammatory Diseases
Previous Article in Journal / Special Issue
Vaccination with LytA, LytC, or Pce of Streptococcus pneumoniae Protects against Sepsis by Inducing IgGs That Activate the Complement System
 
 
Article

Article Versions Notes

Vaccines 2021, 9(3), 187; https://doi.org/10.3390/vaccines9030187
Action Date Notes Link
article pdf uploaded. 24 February 2021 12:53 CET Version of Record https://www.mdpi.com/2076-393X/9/3/187/pdf-vor
article supplementary file uploaded. 24 February 2021 12:53 CET - https://www.mdpi.com/2076-393X/9/3/187#supplementary
article xml file uploaded 2 March 2021 06:05 CET Original file -
article xml uploaded. 2 March 2021 06:05 CET Update https://www.mdpi.com/2076-393X/9/3/187/xml
article pdf uploaded. 2 March 2021 06:05 CET Updated version of record https://www.mdpi.com/2076-393X/9/3/187/pdf
article html file updated 2 March 2021 06:06 CET Original file -
article html file updated 16 March 2021 03:25 CET Update -
article html file updated 25 July 2022 04:49 CEST Update https://www.mdpi.com/2076-393X/9/3/187/html
Back to TopTop